Clinical Trial Update: The Boston Scientific ACCESS Trial [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 trial called ACCESS by Maquet Cardiovascular investigating renal disease and kidney failure has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• End-stage Renal Disease

Snippet

Sponsor: Maquet Cardiovascular | Conditions: Renal Disease, Kidney Failure | Phase 2, Phase 3 | Status: TERMINATED